Maddalena Adorno

CEO & Co-Founder

CEO and co-founder of Dorian Therapeutics. PhD at Stanford with a focus on epigenetics and senescence. Awards: Forbes 30 Under 30 (Healthcare). Her research on modulating epigenetic regulators for aging diseases led her to found one of the most innovative biotechs in the sector.